JP2021535935A5 - - Google Patents

Info

Publication number
JP2021535935A5
JP2021535935A5 JP2021547984A JP2021547984A JP2021535935A5 JP 2021535935 A5 JP2021535935 A5 JP 2021535935A5 JP 2021547984 A JP2021547984 A JP 2021547984A JP 2021547984 A JP2021547984 A JP 2021547984A JP 2021535935 A5 JP2021535935 A5 JP 2021535935A5
Authority
JP
Japan
Prior art keywords
maltodextrin
pluronic
cmc
nanoemulsion
trehalose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021547984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535935A (ja
Filing date
Publication date
Priority claimed from IL261132A external-priority patent/IL261132A/en
Application filed filed Critical
Publication of JP2021535935A publication Critical patent/JP2021535935A/ja
Publication of JP2021535935A5 publication Critical patent/JP2021535935A5/ja
Pending legal-status Critical Current

Links

JP2021547984A 2018-08-13 2019-03-11 ナノ乳化による製剤化カンナビス油粉末、その製造方法、及びその使用 Pending JP2021535935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL261132A IL261132A (en) 2018-08-13 2018-08-13 Formulated cannabis oil powder by nanoemulsifycation, methods of producing and uses thereof
IL261132 2018-08-13
PCT/IL2019/050268 WO2020035850A1 (en) 2018-08-13 2019-03-11 Formulated cannabis oil powder by nanoemulsifycation, methods of producing and uses thereof

Publications (2)

Publication Number Publication Date
JP2021535935A JP2021535935A (ja) 2021-12-23
JP2021535935A5 true JP2021535935A5 (enExample) 2022-01-25

Family

ID=63998426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547984A Pending JP2021535935A (ja) 2018-08-13 2019-03-11 ナノ乳化による製剤化カンナビス油粉末、その製造方法、及びその使用

Country Status (9)

Country Link
US (2) US11712430B2 (enExample)
EP (1) EP3716946A1 (enExample)
JP (1) JP2021535935A (enExample)
CN (1) CN113473965A (enExample)
AU (1) AU2019322212B2 (enExample)
BR (1) BR112021009869A2 (enExample)
CO (1) CO2021007647A2 (enExample)
IL (2) IL261132A (enExample)
WO (1) WO2020035850A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3138630A1 (en) * 2019-05-02 2020-11-05 Betterlife Pharma Inc. Cannabinoid stock transdermal formulations
US10780075B1 (en) 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
AU2020330527A1 (en) * 2019-08-12 2022-02-24 Tenshi Kaizen Private Limited Cannabidiol orally disintegrating tablets
IL295386A (en) * 2020-07-29 2022-10-01 Karnak Tech Llc Improved formulations of lipophilic subtances for cosmetic uses
EP4057993A2 (en) 2020-07-29 2022-09-21 Karnak Technologies, LLC Oral compositions of lipophilic diety supplements, nutraceuticals and beneficial edible oils
AU2021317263B2 (en) * 2020-07-29 2024-08-01 Karnak Technologies, Llc Pharmaceutical compositions for improved delivery of therapeutic lipophilic actives
IL300499A (en) * 2020-08-14 2023-04-01 Capheads Llc Dosing capsule made from cannabis-derived resin and methods of making the same
CA3114085A1 (en) * 2021-04-05 2022-10-05 MEC11S Inc. Composition comprising cannabis extracts and method of manufacturing same
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
CN121752266A (zh) 2023-06-16 2026-03-27 湃珂知识产权有限责任公司 用于产生具有抗生素特性的大麻素皮米级乳剂的方法和所得的皮米级乳剂
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles
US12667578B2 (en) 2024-07-25 2026-06-30 Visionary Assets, Llc Cryogenic process for making cannabinoid nanoparticles and compositions made thereby
WO2026037496A1 (en) * 2024-08-14 2026-02-19 Tetra Pharm Technologies A self-emulsifying solid composition comprising a cannabinoid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011092690A1 (en) 2010-01-26 2011-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions and methods for prevention and treatment of pulmonary hypertension
US8629177B2 (en) * 2010-08-24 2014-01-14 Aphios Corporation Nanoencapsulated delta-9-tetrahydrocannabinol
ES2739194T3 (es) 2012-01-19 2020-01-29 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Formulación y método para aumentar la biodisponibilidad oral de fármacos
WO2013172999A1 (en) 2012-05-16 2013-11-21 Mewa Singh Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
US10213391B2 (en) 2014-05-06 2019-02-26 Mewa Singh Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
US20160058866A1 (en) 2014-09-02 2016-03-03 Ronald D. Sekura Alternative solutions for the administration of cannabis derived botanical products
US9629886B2 (en) 2015-02-24 2017-04-25 Ers Holdings, Llc Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
EP3270896A4 (en) 2015-03-19 2018-09-12 One World Cannabis Ltd. Preparations of cannabis emulsions and methods thereof
DK3302437T4 (da) * 2015-05-28 2026-02-23 Fresh Cut Dev Llc Stabile cannabinoidformuleringer
BR102015024165A2 (pt) * 2015-09-18 2017-03-28 Prati Donaduzzi & Cia Ltda composição farmacêutica oral compreendendo canabinóide, processo para sua preparação e seu uso
DK3368014T3 (da) * 2015-10-26 2024-01-08 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Nye formuleringer af cannabinoider
US20180206518A1 (en) 2016-04-15 2018-07-26 Ronald Silver Method of making cannabis oil hydrophilic using emulsifiers and related cannabinoid compositions
US20200215022A1 (en) * 2016-12-20 2020-07-09 Tilray, Inc. Novel cannabinoid compositions and methods of treating pediatric epilepsy
CO2017007962A1 (es) * 2017-08-04 2018-04-19 Alsec Alimentos Secos S A S Nanoparticulas oleosas de cannabis microencapsuladas en polvo

Similar Documents

Publication Publication Date Title
EP1476473B1 (en) Novel natural cyclodextrin complexes
US20230321031A1 (en) Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof
CA2476833C (en) Novel methylated cyclodextrin complexes
US20160058866A1 (en) Alternative solutions for the administration of cannabis derived botanical products
US20230087359A1 (en) Cannabinoid compositions and methods of use thereof
WO2020146478A1 (en) Cannabinoid formulations for treating alcohol hangover
JP7778069B2 (ja) 高親油性生理活性物質の放出制御製剤
US12491452B2 (en) Extraction method and composition obtained therefrom
US11752108B2 (en) Gold particles including an oleo-gum resin and/or a derivative thereof and methods of preparing and using the same
JP2024535871A5 (enExample)
US20180263954A1 (en) Sustained Release Cannabinoid Formulations
US11291647B2 (en) Process for preparation of CO2 extract of Azadirachta indica and herbal compositions thereof for treatment of cancers
US11285184B2 (en) Cannabidiol alkaline composition
JP2022521711A5 (enExample)
Al-Khazaleh et al. Elucidating the neuroinflammatory and neuroprotective activity of phytochemicals in Cannabis Sativa and their potential entourage effects
Verma et al. Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases
da Silva et al. Potential use of nanoencapsulated cannabinoids for the treatment of inflammatory bowel diseases: a systematic review
WO2024097327A1 (en) Cannabinoid formulations and use for treatment of emotional disorders and sexual dysfunction
JP2026034780A (ja) 高親油性生理活性物質の放出制御製剤